whereas in patients of group i no changes of lipid and lipoprotein parameters were observed , daily oral doses of 200 mg mpa and more led to a marked fall in alpha-lipoprotein- , hdl-cholesterol and apolipoprotein a1 levels . beta-lipoprotein- , ldl-cholesterol and apolipoprotein b concentrations rose significantly in groups iii and iv .
C0023779
lipid
C0023820
lipoprotein